These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 28587866

  • 1. Digging more in the genetic risk prediction of hepatitis C virus epidemic in Egypt: Apoptosis genes polymorphisms in the susceptibility of hepatitis C virus and association with viral load.
    Khalifa RH, Shahin RMH, Aboukhalil REE, Marie MA, El-Deeb AM, Riad NM.
    Virus Res; 2017 Jun 15; 238():35-39. PubMed ID: 28587866
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of ApoB-516C/T promoter gene polymorphism in the risk of Hepatitis C virus infection in Egyptian patients and in gender susceptibility.
    Khalifa RH, Labib DA, Kamel MA, Shahin RMH, Bahgat DMR, Riad NM, El Khateeb E, El-Deeb AM, Hassan M.
    J Med Virol; 2017 Sep 15; 89(9):1584-1589. PubMed ID: 28370191
    [Abstract] [Full Text] [Related]

  • 4. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
    Sarwar R, Mansoor Q, Farooqi AA, Shahzad S, Fayyaz S, Ismail M.
    Cell Mol Biol (Noisy-le-grand); 2015 Dec 19; 61(8):53-6. PubMed ID: 26718429
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Polymorphisms rs763110 in FASL is linked to hepatitis C virus infection among high-risk populations.
    Huang P, Wang CH, Zhuo LY, Xia XS, Yang S, Zhang JW, Fan HZ, Wu JJ, Yu R, Yue M, Zhang Y.
    Br J Biomed Sci; 2020 Jul 19; 77(3):112-117. PubMed ID: 32209020
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interleukin-12B gene polymorphism frequencies in Egyptians and sex-related susceptibility to hepatitis C infection.
    Youssef SS, Mostafa A, Nasr AS, el Zanaty T, Seif SM.
    J Interferon Cytokine Res; 2013 Aug 19; 33(8):415-9. PubMed ID: 23600862
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.
    Zhao H, Chen W, Du P, Sun A, Zhuang C, Tong J, Wang L.
    Tumour Biol; 2015 Jun 19; 36(6):4319-26. PubMed ID: 25596086
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
    Alsalawy NF, Darwish RK, Kamal MM, ElTaweel AE, Shousha HI, Elbaz TM.
    J Med Virol; 2018 Mar 19; 90(3):490-496. PubMed ID: 28975649
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.
    Zamani AG, Barlas IO, Durakbasi-Dursun G, Ural O, Erdal E, Yildirim MS.
    Int J Immunogenet; 2013 Dec 19; 40(6):482-7. PubMed ID: 23560484
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.